These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10566594)

  • 21. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of a new molecule IK in CD34+ hematopoietic progenitor cell proliferation and differentiation.
    Cao LX; Le Bousse-Kerdiles MC; Clay D; Oshevski S; Jasmin C; Krief P
    Blood; 1997 May; 89(10):3615-23. PubMed ID: 9160666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
    Lee JW; Gersuk GM; Kiener PA; Beckham C; Ledbetter JA; Deeg HJ
    J Immunol; 1997 Oct; 159(7):3211-9. PubMed ID: 9317119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
    Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.
    Greinix HT; Storb R; Bartelmez SH
    Blood; 1992 Oct; 80(8):1950-6. PubMed ID: 1382714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
    Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
    Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4 and interferon gamma costimulate the expansion of early human myeloid colony-forming cells. Proposal of a model for the regulation of myelopoiesis by interleukin 4 and interferon gamma and its integration with the regulation of the immune response.
    Snoeck HW; Lenjou M; Nys G; Lardon F; Peetermans ME; Van Bockstaele DR; Moulijn A; Haenen L; Berneman ZN
    Leukemia; 1996 Jan; 10(1):117-22. PubMed ID: 8558915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
    Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
    Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth and differentiation of human dendritic cells from CD34+ progenitors.
    Szabolcs P; Ciocon DH; Moore MA; Young JW
    Adv Exp Med Biol; 1997; 417():15-9. PubMed ID: 9286331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.
    Srour EF; Brandt JE; Briddell RA; Leemhuis T; van Besien K; Hoffman R
    Blood Cells; 1991; 17(2):287-95. PubMed ID: 1717081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of Fas (APO-1, CD95) on CD34+ haematopoietic progenitor cells after allogeneic bone marrow transplantation.
    Saheki K; Fujimori Y; Takemoto Y; Kakishita E
    Br J Haematol; 2000 May; 109(2):447-52. PubMed ID: 10848840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles of I and sialosyl-I antigens on blood cells: the sialosyl-I antigen is expressed along the monocytic differentiation.
    Muroi K; Handa K; Amemiya Y; Hakomori S; Ozawa K; Miura Y
    Leuk Res; 1998 Nov; 22(11):1029-36. PubMed ID: 9783806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha.
    Szabolcs P; Feller ED; Moore MA; Young JW
    Adv Exp Med Biol; 1995; 378():17-20. PubMed ID: 8526047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens.
    Falkenburg JH; Fibbe WE; Goselink HM; Van Rood JJ; Jansen J
    J Exp Med; 1985 Oct; 162(4):1359-69. PubMed ID: 3862746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.
    Bhalla K; Ibrado AM; Bradt JE; Ray S; Huang Y; Tang C; Nawabi A; Hoffman R
    Leukemia; 1995 Nov; 9(11):1851-6. PubMed ID: 7475274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colony formation of human fetal CD34+ hematopoietic cells.
    Ek S; Markling L; Ringdén O; Kjeldgaard A; Westgren M
    Fetal Diagn Ther; 1996; 11(5):326-34. PubMed ID: 8894627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.